FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

37228411000001106: Vizimpro 30mg tablets (Pfizer Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Jun 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
247091000001112 Vizimpro 30mg tablets (Pfizer Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
247101000001118 Vizimpro 30mg tablets (Pfizer Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vizimpro 30mg tablets (Pfizer Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Vizimpro 30mg tablets (Pfizer Ltd) Is a Dacomitinib 30mg tablets true Inferred relationship Existential restriction modifier
Vizimpro 30mg tablets (Pfizer Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Vizimpro 30mg tablets (Pfizer Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Vizimpro 30mg tablets (Pfizer Ltd) Is a Vizimpro true Inferred relationship Existential restriction modifier
Vizimpro 30mg tablets (Pfizer Ltd) Has specific active ingredient Dacomitinib monohydrate false Inferred relationship Existential restriction modifier
Vizimpro 30mg tablets (Pfizer Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Vizimpro 30mg tablets (Pfizer Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Vizimpro 30mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Vizimpro 30mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Dacomitinib false Inferred relationship Existential restriction modifier
Vizimpro 30mg tablets (Pfizer Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Vizimpro 30mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Vizimpro 30mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Vizimpro 30mg tablets (Pfizer Ltd) Has specific active ingredient Dacomitinib monohydrate true Inferred relationship Existential restriction modifier
Vizimpro 30mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Dacomitinib true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Vizimpro 30mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has AMP True Vizimpro 30mg tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start